The company's commercial viability remains severely constrained, with gross margins plummeting to -7296.1% in 2026Q1 due to fixed overheads decoupled from negligible sales.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Sales/Revenue | 18.11K | 124.16K | 20.73K | 122.11K | 3.52M | 594.56K | 16.56K | 11.73K | 77.72K | 250.93K | 0 | 1.98K | 0 | 0 | 530 | 58.4K | 5.15K | 52.25K | 109.84K | 70.07K | 133.94K | 154.56K | 51.51K | 99.59K | 79.73K | 703.89K | 53.76K | 2.4K | 222.29K | 652.66K | 668.79K |
| Revenue Growth % | -82.95% | 498.95% | -83.02% | -96.53% | 491.97% | 3489.71% | 41.19% | -84.91% | -69.03% | - | -100% | - | - | -100% | -99.09% | 1033.88% | -90.14% | -52.43% | 56.75% | -47.69% | -13.34% | 200.09% | -48.28% | 24.92% | -88.67% | 1209.42% | 2139.83% | -98.92% | -65.94% | -2.41% | -52.23% |
| Cost of Goods Sold | 4.78M | 4.8M | 52.59K | 375.85K | 2.11M | 184.18K | 11.28K | 8.77K | 64.88K | 60.32K | 25.96K | 19.77K | 0 | 0 | 212 | 4.35K | 2.94K | 25.81K | 54.62K | 680 | 258 | 22.46K | 14.95K | 4.01K | 0 | 0 | 0 | -25.72K | 0 | 0 | 0 |
| COGS % of Revenue | - | 3867.2% | 253.73% | 307.79% | 60.07% | 30.98% | 68.09% | 74.78% | 83.47% | 24.04% | - | 1001.11% | - | - | 40% | 7.46% | 57.15% | 49.4% | 49.72% | 0.97% | 0.19% | 14.53% | 29.02% | 4.03% | - | - | - | -1071.75% | - | - | - |
| Gross Profit | -4.76M | -4.68M | -31.87K | -253.73K | 1.41M | 410.38K | 5.29K | 2.96K | 12.85K | 190.61K | -25.96K | -17.8K | 0 | 0 | 318 | 54.04K | 2.21K | 26.44K | 55.22K | 69.39K | 133.68K | 132.11K | 36.56K | 95.58K | 79.73K | 703.89K | 53.76K | 28.12K | 222.29K | 652.66K | 668.79K |
| Gross Margin % | -26296.83% | -3767.2% | -153.73% | -207.79% | 39.93% | 69.02% | 31.91% | 25.22% | 16.53% | 75.96% | - | -901.11% | - | - | 60% | 92.54% | 42.85% | 50.6% | 50.28% | 99.03% | 99.81% | 85.47% | 70.98% | 95.97% | 100% | 100% | 100% | 1171.75% | 100% | 100% | 100% |
| Gross Profit Growth % | - | -14577.84% | 87.44% | -118.05% | 242.45% | 7663.56% | 78.64% | -76.97% | -93.26% | 834.37% | -45.84% | - | - | -100% | -99.41% | 2348.62% | -91.65% | -52.11% | -20.42% | -48.09% | 1.19% | 261.38% | -61.75% | 19.88% | -88.67% | 1209.42% | 91.15% | -87.35% | -65.94% | -2.41% | -52.23% |
| Operating Expenses | 8.35M | 9.31M | 13.81M | 12.95M | 15.38M | 4.28M | 1.45M | 1.58M | 1.35M | 770.38K | 667.11K | 521.8K | 566.15K | 566.15K | 554.93K | 1.2M | 1.07M | 1.67M | 1.89M | 2.49M | 2.82M | 680.47K | 533.43K | 568.12K | 686.51K | 1.09M | 3.37M | 6.21M | 2.44M | 3.01M | 2.16M |
| OpEx % of Revenue | - | 7501.12% | 66618.45% | 10607.2% | 437.02% | 719.49% | 8728.62% | 13497.33% | 1733.73% | 307.01% | - | 26420.05% | - | - | 104703.02% | 2054.84% | 20806.23% | 3191.13% | 1722.55% | 3550.36% | 2107.72% | 440.25% | 1035.67% | 570.43% | 861.04% | 155.26% | 6262.25% | 258923.29% | 1096.81% | 460.56% | 323.11% |
| Selling, General & Admin | 1.82M | 1.56M | 5.4M | 5.64M | 8.54M | 2.36M | 1.45M | 1.53M | 1.31M | 770.38K | 667.11K | 521.8K | 433.19K | 433.19K | 355.33K | 918.81K | 638.16K | 1.2M | 1.37M | 1.96M | 2.29M | 492.66K | 362.39K | 394.77K | 303.63K | 576.57K | 1.09M | 1.46M | 1.07M | 1.36M | 1.52M |
| SG&A % of Revenue | - | 1259.21% | 26028.34% | 4614.84% | 242.51% | 396.45% | 8726.27% | 13049.71% | 1691.8% | 307.01% | - | 26420.05% | - | - | 67042.83% | 1573.45% | 12391.53% | 2301.65% | 1243.74% | 2792.73% | 1708.24% | 318.74% | 703.58% | 396.38% | 380.82% | 81.91% | 2027.37% | 60669.67% | 479.21% | 207.68% | 226.76% |
| Research & Development | 6.53M | 7.75M | 8.41M | 7.32M | 6.85M | 1.92M | 389 | 52.51K | 32.59K | 0 | 0 | 0 | 132.96K | 132.96K | 199.6K | 281.11K | 433.36K | 464.79K | 525.9K | 530.87K | 535.08K | 187.81K | 171.04K | 173.34K | 382.88K | 516.29K | 2.28M | 4.73M | 1.37M | 1.65M | 644.37K |
| R&D % of Revenue | - | 6241.91% | 40590.11% | 5992.36% | 194.51% | 323.03% | 2.35% | 447.62% | 41.93% | - | - | - | - | - | 37660.19% | 481.39% | 8414.7% | 889.48% | 478.81% | 757.63% | 399.48% | 121.51% | 332.08% | 174.05% | 480.22% | 73.35% | 4234.88% | 197181.88% | 617.6% | 252.88% | 96.35% |
| Other Operating Expenses | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 25.72K | 0 | 0 | 0 |
| Operating Income | -13.11M | -13.99M | -13.84M | -13.21M | -13.98M | -3.87M | -1.44M | -1.58M | -1.33M | -579.76K | -667.11K | -519.82K | -622.6K | -566.15K | -554.61K | -1.15M | -1.07M | -1.64M | -1.84M | -2.42M | -2.69M | -548.36K | -496.87K | -472.53K | -606.78K | -388.97K | -3.31M | -6.19M | -2.22M | -2.35M | -1.49M |
| Operating Margin % | -72393.48% | -11268.32% | -66772.17% | -10814.99% | -397.09% | -650.47% | -8696.7% | -13472.11% | -1717.2% | -231.05% | - | -26320.05% | - | - | -104643.02% | -1962.29% | -20763.38% | -3140.52% | -1672.27% | -3451.34% | -2007.91% | -354.78% | -964.69% | -474.46% | -761.04% | -55.26% | -6162.25% | -257751.54% | -996.81% | -360.56% | -223.11% |
| Operating Income Growth % | - | -1.08% | -4.81% | 5.51% | -261.38% | -168.49% | 8.86% | -18.41% | -130.21% | 13.09% | -28.33% | 16.51% | -9.97% | -2.08% | 51.6% | -7.16% | 34.84% | 10.66% | 24.05% | 10.08% | -390.45% | -10.36% | -5.15% | 22.12% | -56% | 88.26% | 46.45% | -179.18% | 5.84% | -57.71% | -86.52% |
| EBITDA | -8.33M | -9.21M | -9.04M | -8.34M | -9.16M | -1.82M | -1.43M | -1.56M | -1.28M | -539.77K | -641.15K | -500.05K | -605.06K | -550.03K | -539.04K | -1.13M | -1.05M | -1.62M | -1.82M | -2.4M | -2.67M | -535.92K | -467.83K | -450.39K | -583.95K | -366.04K | -3.29M | -6.16M | -2.19M | -2.32M | -1.47M |
| EBITDA Margin % | -46017.5% | -7418.23% | -43607.93% | -6825.98% | -260.33% | -306.61% | -8607.96% | -13282.52% | -1644.9% | -215.11% | - | -25318.94% | - | - | -101704.91% | -1933.87% | -20377.92% | -3098.46% | -1654.27% | -3424.53% | -1996.58% | -346.73% | -908.31% | -452.22% | -732.4% | -52% | -6117.65% | -256679.79% | -984.23% | -356.11% | -219.23% |
| EBITDA Growth % | 8.48% | -1.89% | -8.45% | 9.03% | -402.61% | -27.86% | 8.5% | -21.88% | -136.86% | 15.81% | -28.22% | 17.36% | -10% | -2.04% | 52.27% | -7.61% | 35.18% | 10.89% | 24.28% | 10.27% | -399% | -14.55% | -3.87% | 22.87% | -59.53% | 88.87% | 46.62% | -181.57% | 5.87% | -58.52% | -4.73% |
| D&A (Non-Cash Add-back) | 4.78M | 4.78M | 4.8M | 4.87M | 4.81M | 2.04M | 14.7K | 22.24K | 56.19K | 39.99K | 25.96K | 19.77K | 17.54K | 16.12K | 15.57K | 16.6K | 19.85K | 21.98K | 19.77K | 18.78K | 15.18K | 12.44K | 29.04K | 22.14K | 22.83K | 22.93K | 23.98K | 25.72K | 27.96K | 29.04K | 25.97K |
| EBIT | -13.11M | -13.99M | -14.25M | -13.63M | -13.95M | -3.87M | -1.44M | -1.58M | -1.33M | -579.76K | -667.11K | -519.82K | -469.03K | -566.15K | -495.29K | -1.1M | 600.26K | -1.64M | -1.84M | -2.42M | -2.69M | -548.36K | -496.87K | -472.53K | -606.78K | -388.97K | -3.36M | -6.19M | -2.22M | -2.35M | -1.49M |
| Net Interest Income | -708.33K | -711.9K | -616.47K | -144.19K | -53.53K | -18.69K | -10.19K | -885 | -3.96K | -37.61K | 0 | 0 | -1.89K | 0 | -155.56K | -211.72K | -93.95K | -89.76K | -86.31K | -87.76K | -90.11K | -120.65K | -98.33K | -97.96K | -97.31K | -92.64K | -35.81K | 0 | -117K | 0 | -126.06K |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.4K | 6.13K | 2.89K | 3.03K | 0 | 0 | 0 | 1.74K | 2.34K | 47.02K | 0 | 0 | 0 | 0 |
| Interest Expense | 708.33K | 711.9K | 616.47K | 144.19K | 53.53K | 18.69K | 10.19K | 885 | 3.96K | 37.61K | 2.87K | 2.05K | 1.89K | 103.37K | 155.56K | 211.72K | 93.95K | 93.16K | 92.44K | 90.65K | 93.15K | 120.65K | 98.33K | 97.96K | 99.05K | 94.98K | 82.82K | 0 | 117K | 0 | 126.06K |
| Other Income/Expense | -832.81K | -779.8K | -1.02M | -563.35K | -30.48K | -5.09K | -10.19K | -885 | -3.96K | -37.61K | -2.87K | -2.05K | 3.42M | -56.45K | -96.24K | -167.89K | 1.58M | -1.33M | -86.31K | -87.76K | -88.22K | -120.65K | -98.33K | 472.53K | 8.71K | 0 | 58.66K | -5.74K | -117K | -118.06K | -126.06K |
| Pretax Income | -13.94M | -14.77M | -14.86M | -13.77M | -14.01M | -3.87M | -1.45M | -1.58M | -1.34M | -617.38K | -669.98K | -521.87K | -622.6K | -622.6K | -650.85K | -1.31M | 506.31K | -2.97M | -1.92M | -2.51M | -2.78M | -669.01K | 0 | 314.88K | -598.07K | 0 | -3.31M | -6.19M | -2.33M | -2.47M | -1.62M |
| Pretax Margin % | -76991.83% | -11896.4% | -71698.4% | -11276.33% | -397.96% | -651.32% | -8758.21% | -13479.65% | -1722.3% | -246.04% | - | -26424% | - | - | -122801.32% | -2249.8% | 9831.3% | -5686.09% | -1750.85% | -3576.58% | -2073.78% | -432.83% | - | 316.17% | -750.12% | - | -6149.72% | -257990.5% | -1049.45% | -378.64% | -241.96% |
| Income Tax | 800 | 800 | 800 | 800 | 0 | 16.14K | 0 | 0 | 0 | 0 | 0 | 0 | 3.29M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 98.33K | -639.16K | 99.05K | 92.64K | 82.82K | -67.45K | 0 | 0 | 0 |
| Effective Tax Rate % | -0.01% | -0.01% | -0.01% | -0.01% | 0% | -0.42% | 0% | 0% | 0% | 0% | 0% | 0% | -528.62% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | - | -202.98% | -16.56% | - | -2.51% | 1.09% | 0% | 0% | 0% |
| Net Income | -13.94M | -14.77M | -14.86M | -13.77M | -14.01M | -3.89M | -1.45M | -1.58M | -1.34M | -617.38K | -669.98K | -521.87K | -622.6K | -622.6K | -650.85K | -1.31M | 506.31K | -2.97M | -1.92M | -2.51M | -2.78M | -669.01K | -595.21K | 166.63K | -705.82K | -481.61K | -3.4M | -6.12M | -2.33M | -2.47M | -1.62M |
| Net Margin % | -76996.25% | -11897.04% | -71702.26% | -11276.98% | -397.96% | -654.04% | -8758.21% | -13487.2% | -1722.3% | -246.04% | - | -26424% | - | - | -122801.32% | -2249.8% | 9831.3% | -5686.09% | -1750.85% | -3576.58% | -2073.78% | -432.83% | -1155.6% | 167.31% | -885.27% | -68.42% | -6316.33% | -254941.08% | -1049.45% | -378.64% | -241.96% |
| Net Income Growth % | 6% | 0.62% | -7.93% | 1.69% | -260.19% | -168.07% | 8.32% | -18.19% | -116.83% | 7.85% | -28.38% | 16.18% | 0% | 4.34% | 50.46% | -359.48% | 117.04% | -54.5% | 23.26% | 9.78% | -315.19% | -12.4% | -457.2% | 123.61% | -46.56% | 85.82% | 44.51% | -162.28% | 5.6% | -52.72% | -439.4% |
| Net Income (Continuing) | -13.94M | -14.77M | -14.86M | -13.77M | -14.01M | -3.89M | -1.45M | -1.58M | -1.34M | -617.38K | -669.98K | -521.87K | 2.84M | -622.6K | -650.85K | -1.31M | 506.31K | -2.97M | -1.92M | -2.51M | -2.78M | -669.01K | -595.21K | 166.63K | -705.82K | -481.61K | -3.4M | -6.12M | -2.33M | -2.47M | -1.62M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -2.31 | -3.46 | -1.56 | -3.36 | -5.14 | -2.59 | -2.69 | -0.74 | -0.56 | -0.41 | -0.50 | -0.39 | -0.83 | -2.42 | -2.53 | -5.76 | 2.85 | -20.03 | -17.65 | -26.88 | -35.22 | -11.56 | -13.63 | 5.70 | -22.69 | -17.48 | -125.43 | -274.09 | -122.80 | -130.09 | -117.06 |
| EPS Growth % | 98.61% | -121.79% | 53.57% | 34.63% | -98.46% | 3.72% | -263.51% | -32.14% | -36.59% | 18% | -28.21% | 53.01% | 65.7% | 4.35% | 56.08% | -302.11% | 114.23% | -13.48% | 34.34% | 23.68% | -204.67% | 15.19% | -339.12% | 125.12% | -29.81% | 86.06% | 54.24% | -123.2% | 5.6% | -11.13% | -310.74% |
| EPS (Basic) | - | -3.46 | -1.56 | -3.36 | -5.14 | -2.59 | -2.69 | -0.74 | -0.56 | -0.41 | -0.50 | -0.39 | -0.83 | -2.42 | -2.53 | -5.76 | 2.85 | -20.03 | -17.65 | -26.88 | -35.22 | -11.56 | -13.63 | 5.70 | -22.69 | -17.48 | -125.43 | -274.09 | -122.80 | -130.09 | -117.06 |
| Diluted Shares Outstanding | 6.03M | 4.27M | 9.5M | 4.1M | 2.73M | 1.51M | 543.08K | 2.15M | 2.38M | 1.51M | 1.34M | 1.34M | 746K | 257.7K | 257.43K | 228.17K | 199.61K | 148.34K | 108.94K | 93.23K | 78.88K | 57.88K | 43.67K | 34.39K | 31.1K | 27.55K | 27.07K | 22.32K | 19K | 19K | 13.82K |
| Basic Shares Outstanding | 6.03M | 4.27M | 9.5M | 4.1M | 2.73M | 1.51M | 543.08K | 2.15M | 2.38M | 1.51M | 1.34M | 1.34M | 746K | 257.7K | 257.43K | 228.17K | 193.13K | 148.34K | 108.94K | 93.23K | 78.88K | 57.88K | 43.67K | 34.39K | 31.1K | 27.55K | 27.07K | 22.32K | 19K | 19K | 13.82K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Imminent liquidity insolvency risk
As reported in recent financial filings, Ainos generated a nominal $161 in revenue for 2026Q1, reflecting a near-total collapse from previous periods and underscoring the company's inability to establish a sustainable, recurring revenue stream across its diagnostic and synthetic RNA technology platforms in the current market environment.
The extreme volatility and negligible absolute revenue figures suggest that the company's top line is driven by sporadic, non-recurring contracts rather than a repeatable business model. Investors should monitor whether the pivot toward VOC sensing can generate meaningful commercial traction, as current data indicates the firm remains in a pre-revenue state.
Based on the company's reported income statements, gross margins have remained deeply negative, reaching -7296.1% in 2026Q1, which suggests that the cost of goods sold is heavily burdened by fixed manufacturing overheads that are entirely decoupled from the firm's current, minimal sales volume.
This margin profile implies that the company is effectively subsidizing its production capacity without achieving the necessary scale to cover basic variable costs. Such structural inefficiency warrants further investigation into whether the current manufacturing strategy is viable or if it requires a fundamental shift to a lower-cost, outsourced model.
According to quarterly data, Ainos continues to incur significant R&D expenditures, with $1.1 million reported in 2026Q1, which highlights a persistent reliance on high-burn operational spending despite the absence of a corresponding revenue base to support these ongoing clinical and technological development activities.
The company's cost structure appears to be prioritized toward long-term R&D at the expense of immediate financial stability. This strategy may indicate a management focus on achieving regulatory milestones, yet it leaves the firm highly exposed to capital market volatility given the lack of internal cash generation.
As indicated by the provided financial statements, the company's operating losses consistently exceed its cash reserves, creating a precarious financial position that suggests the firm may be forced to pursue dilutive equity financing to maintain its ongoing research and development operations in the near term.
The disconnect between the company's ambitious technological goals and its limited liquidity profile suggests that the current trajectory may be unsustainable without a major strategic partnership or capital injection. Investors should remain cautious regarding the potential for significant shareholder dilution as the firm attempts to bridge its funding gap.
Quick answers to the most common questions about buying AIMD stock.
For fiscal year 2025, Ainos, Inc. (AIMD) reported total revenue of $0.1M. This represents a 81.4% decline compared to $0.7M in 1996.
Ainos, Inc. (AIMD) reported a net loss of $14.8M for the fiscal year ending 2025.
Ainos, Inc. (AIMD) reported an operating income of $-14.0M, resulting in an operating profit margin of -11268.3%. This margin reflects the operational efficiency of the business before interest and taxes.
Ainos, Inc. (AIMD) generated $-4.7M in gross profit for the year, representing a gross profit margin of -3767.2%. This demonstrates the company's core pricing power and production efficiency.